Maarsingh, H.; Oldenburger, A.; Han, B.; Zuidhof, A.B.; Elzinga, C.R.S.; Timens, W.; Meurs, H.; Sopi, R.B.; Schmidt, M.
Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction. Cells 2021, 10, 1237.
https://doi.org/10.3390/cells10051237
AMA Style
Maarsingh H, Oldenburger A, Han B, Zuidhof AB, Elzinga CRS, Timens W, Meurs H, Sopi RB, Schmidt M.
Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction. Cells. 2021; 10(5):1237.
https://doi.org/10.3390/cells10051237
Chicago/Turabian Style
Maarsingh, Harm, Anouk Oldenburger, Bing Han, Annet B. Zuidhof, Carolina R. S. Elzinga, Wim Timens, Herman Meurs, Ramadan B. Sopi, and Martina Schmidt.
2021. "Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction" Cells 10, no. 5: 1237.
https://doi.org/10.3390/cells10051237
APA Style
Maarsingh, H., Oldenburger, A., Han, B., Zuidhof, A. B., Elzinga, C. R. S., Timens, W., Meurs, H., Sopi, R. B., & Schmidt, M.
(2021). Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction. Cells, 10(5), 1237.
https://doi.org/10.3390/cells10051237
